Replies to post #493630 on Anavex Life Sciences Corp (AVXL)

[williamssc]

Blarcamesine long term efficacy and safety data is far superior to anything on the market. It's getting late in the game and shorts are worried.

[Steady_T]

If you read that short report then you saw how the report managed to avoid mentioning almost anything positive about the study including the peer reviewed paper. It did however manage to amplify and awfulize anything negative that can be said about the P3 trial.

The good thing is the bias was up front in the title, Short Report, so I have to give the author credit for that.

[georgejjl]

Per your request

GOD bless,